Science Pool

Evotec SE fiscal year 2021 results: "Setting the Pace" on the data-driven R&D Autobahn to Cures

Evotec SE today reported financial results and corporate updates for the fiscal year ended 31 December 2021. Group revenues significantly exceeded the revenue target, up 23% to € 618.0 m; Base business up 18%; Adjusted Group EBITDA in line with guidance at € 107.3 m, up 1%; Unpartnered R&D expenses of € 58.1 m (2020: € 46.4 m up 25%); Very strong liquidity position with € 858.2 m in cash

Read More